Navigation Links
The US Oncology Network Affiliated Physicians at Forefront of Cutting-Edge Prostate Cancer Treatment
Date:9/30/2011

in cancer in the United States and the third most common cancer worldwide. More than two million men in the United States have prostate cancer, with an estimated 240,890 new cases and approximately 33,720 men expected to die from the disease this year.

Individuals interested in learning whether PROVENGE is an appropriate treatment option should contact one of the practices listed above or call 1-877-336-3736.  For full Prescribing Information, please visit www.PROVENGE.com.

About The US Oncology NetworkThe US Oncology Network is one of the nation's largest networks of community-based oncology physicians dedicated to advancing cancer care in America. Like-minded physicians are united through The Network around a common vision of expanding patient access to high-quality, integrated cancer care in communities throughout the nation. Leveraging healthcare information technology, shared best practices, refined evidence-based medicine guidelines, and quality measurements, physicians affiliated with The US Oncology Network are committed to advancing the quality, safety, and science of cancer care to improve patient outcomes. The US Oncology Network is supported by McKesson Specialty Health, a division of McKesson Corporation focused on empowering a vibrant and sustainable community patient care delivery system to advance the science, technology and quality of care. For more information, visit www.usoncology.com.


'/>"/>

SOURCE The US Oncology Network
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
4. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. University of Pennsylvania School of Medicine Study Shows Significant Differences in English- and Spanish-speakers Use of Oncology Websites
7. Statement by US Oncology on FDA Label on Erythropoiesis Stimulating Agents (ESAs)
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. US Oncology Research Network Presents Clinical Studies at San Antonio Breast Cancer Symposium
10. IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
11. Preliminary PI-88 Phase 2 Prostate Cancer Results to be Presented at the American Society for Clinical Oncology (ASCO) 2008 Genitourinary Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... -- WuXi PharmaTech (Cayman) Inc. (NYSE:  WX), a leading ... pharmaceutical, biotechnology, and medical device industries with operations in ... United States , congratulates our partner TaiMed Biologics ... for ibalizumab (TMB355). The FDA designates a drug as ... in combination with one or more other drugs, to ...
(Date:2/27/2015)... , Feb. 27, 2015  Acsis Inc., the market ... solutions, announced today that John DiPalo , Acsis, ... Supply & Demand Chain Executive 2015 Provider Pro ... are leading initiatives to help prepare their companies, and ... business climate. This year,s list of Provider Pros to ...
(Date:2/27/2015)... Securities lawyers at Dunnam & Dunnam ... (NASDAQ: SLXP ) in connection with a ... are encouraged to contact attorney Hamilton Lindley by ... upon the shareholder value of the transaction. Under terms ... $158.00 per share in cash. At least one analyst ...
Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2
... HOUSTON, Sept. 22 On an exploration mission, an astronaut ... the spacecraft speeds to its destination. The ensuing scene is ... grasp on the situation and provide appropriate treatment. Efficient use ... and death. Engineers funded by the National Space ...
... Sept. 22 AlloSource, one of the nation,s largest non-profit ... in surgical procedures and the world,s largest processor of live ... company as judged by the ColoradoBiz Top Company ... each year for the past decade, AlloSource saved and enhanced ...
Cached Medicine Technology:Space-Age Device to Deliver More Efficient Health Care on Earth and Above 2Space-Age Device to Deliver More Efficient Health Care on Earth and Above 3AlloSource Named Colorado's Top Healthcare Company 2
(Date:3/1/2015)... CrossFit Attollo is a CrossFit gym located in Vancouver ... to new members. Now through the end of March ... will receive their fourth month half off. , ... The three month contract is only $264, dropping the price ... comes in at only $55. The special saves new members ...
(Date:2/28/2015)... February 28, 2015 In recent years Medical ... of practicing physicians as a way for them to expand ... regarding Cannabis as medicine. Since the FDA still lists Cannabis ... resources available to licensed physicians that can help guide ... Dr. Deborah Malka in Santa Cruz, CA is a ...
(Date:2/28/2015)... OR (PRWEB) February 28, 2015 In ... Duncan Fletcher of Game Change Athlete ... Shannon Leinert about the benefits of athlete development and ... some of the unique challenges that athletes face and ... and future success. , Fletcher became involved in athlete ...
(Date:2/28/2015)... 2015 With their commitment to achieving ... an additional exercise to their already robust library of ... most commonly known as, is often performed on a ... executed in a relatively safe manner and can be ... The full description of “Rope Pulls” is located in ...
(Date:2/28/2015)... Portland, Oregon (PRWEB) February 28, 2015 ... Portland, Oregon, is offering a new special. Throughout ... denture relines. , This service ... from sleep problems and pain. Patients may notice certain ... and need relining. These symptoms include: , 1.    Pain, ...
Breaking Medicine News(10 mins):Health News:CrossFit Gym in Vancouver WA Offers Spring Special 2Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2
... have found a new family of therapeutic agents that ... growth of breast cancer cells. The results of the ... The Endocrine Society,s 90th Annual Meeting in San Francisco. ... therapeutic called TPBM and related compounds are likely to ...
... have discovered a new family of agents that inhibit ... described today at a meeting of the Endocrine Society, ... to combat estrogen-dependent breast cancers. , "This cell-based study ... to be effective in tumors that remain dependent on ...
... treatments, researchers say , , MONDAY, June 16 (HealthDay News) ... that might one day be added to the armamentarium ... "This is a potential new approach to treating hormonally ... officer of the American Cancer Society. "If it proves ...
... 16 The National Center for Healthcare,Leadership (NCHL) ... MD, chief,executive officer of Denver Health, as the ... her significant and lasting contributions,to healthcare. Under her ... system that achieves organizational,excellence while treating at-risk populations, ...
... S.C., June 16 The planned,Presbyterian College school of ... the dean of the school of pharmacy and assistant,provost ... Charleston,W. Va. has accepted the college,s offer to become ... developing the first school of pharmacy in,Upstate South Carolina., ...
... of RU-486,s companion drug misoprostol is safe, but vaginal use ... a drug given with RU-486 to terminate a pregnancy may ... in women taking the drugs since 2000, a study by ... is FDA-approved to be taken by mouth along with RU-486 ...
Cached Medicine News:Health News:Future hope for patients with breast cancers resistant to tamoxifen 2Health News:Team discovers new inhibitors of estrogen-dependent breast cancer cells 2Health News:New Molecule Discovery Shows Promise Against Tamoxifen-Resistant Breast Cancers 2Health News:Denver Health's Dr. Patricia Gabow Receives NCHL's 2008 National Healthcare Leadership Award 2Health News:Denver Health's Dr. Patricia Gabow Receives NCHL's 2008 National Healthcare Leadership Award 3Health News:Denver Health's Dr. Patricia Gabow Receives NCHL's 2008 National Healthcare Leadership Award 4Health News:Presbyterian College Announces First Dean of New Pharmacy School 2Health News:Presbyterian College Announces First Dean of New Pharmacy School 3Health News:Abortion drug's off-label use may have led to deaths 2Health News:Abortion drug's off-label use may have led to deaths 3
... eyes, oral. Marked with recommended tube ... line. Graduated. Single use. For improved ... of the tube by incorporating a ... the anatomical situation at body temperature. ...
... stylet inside. Sterile, Latex Free, Single ... tube with a preloaded Slick® Stylet ... time and storage space. The stylet ... and has a stopper to help ...
Ruschelit® PVC. Murphy eye-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Medicine Products: